06:43 AM EDT, 08/05/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) reported Q2 non-GAAP earnings Tuesday of $0.25 per diluted share, up from $0.16 per share a year earlier.

Analysts surveyed by FactSet expected non-GAAP earnings of $0.25.

Revenue for the quarter ended June 30 was $724.5 million, up from $701.8 million a year earlier.

Analysts surveyed by FactSet expected $744.6 million.

The company now expects fiscal 2025 non-GAAP earnings per share of $0.70 to $0.75, up from earlier guidance of $0.60 to $0.70 per share.

Analysts surveyed by FactSet IQ expect $0.71 per share.

The company has maintained its earlier guidance for revenue for fiscal 2025, expecting it to be between $3.0 billion to $3.1 billion.

Analysts surveyed by FactSet IQ expect $3.01 billion.

Amneal Pharmaceuticals ( AMRX ) were up 4.3% in recent pre-market trading on Tuesday.